CD160 and B-cell chronic lymphocytic leukemia: T cells from CLL patients show an increased expression of inhibitory receptors (e.g. PD-1, CD160 and CD244), reduced proliferative capacity, limited cytotoxicity and impaired immune synapse formation.5,6 Most studies so far have focused on the effects of CLL on the T cell compartment as a whole.